Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand

Core Viewpoint - Biomerica, Inc. is expanding its Contract Development and Manufacturing Organization (CDMO) services to meet increasing market demand for advanced medical diagnostic solutions [1][2]. Group 1: Company Overview - Biomerica has over 40 years of experience in assay development, manufacturing, and regulatory compliance, making it a sought-after partner for biotechnology and diagnostic companies [2]. - The company is positioned to capture growing demand for outsourced diagnostic development and production, supported by ISO 13485 certification and an FDA registered cGMP manufacturing facility [5]. Group 2: CDMO Services Expansion - The expansion of CDMO services aims to provide end-to-end support from concept through commercial manufacturing, addressing the needs of both large and small diagnostic organizations [3][5]. - Biomerica's CDMO services include capabilities in lateral flow, point-of-care diagnostics, ELISA tests, and Multiplex ELISA assays, which help partners reduce timelines and ensure high-quality outcomes [4][5]. Group 3: Marketing and Visibility - The company has updated its corporate website to prominently feature its CDMO capabilities, facilitating easier access for potential partners to understand the expanded service offerings [4]. - The updated site includes service descriptions and resources to support collaboration with innovators [4]. Group 4: Comprehensive Capabilities - Biomerica offers a range of services including custom assay development, antibody and reagent services, recombinant antibody development, manufacturing and assembly, and supply chain and technology transfer [7][8]. - These services are designed to enhance the efficiency and scalability of product development for pharmaceutical, biotechnology, and diagnostic companies [8].